Skip to main content
Top
Published in: Current Treatment Options in Neurology 11/2016

01-11-2016 | Pediatric Neurology (R-M Boustany, Section Editor)

Diagnosis and Treatment of Childhood Migraine

Authors: Kelsey Merison, MD, Howard Jacobs, MD

Published in: Current Treatment Options in Neurology | Issue 11/2016

Login to get access

Opinion statement

While the diagnosis of migraine in children is generally straightforward, treatment can seem complex with a number of medication choices, many of which are used “off label.” Patients with intermittent migraines can often be managed with ibuprofen or naproxen taken as needed. Unfortunately, by the time that children present to our practice, they have often tried these medications without improvement. Triptans are frequently prescribed to these patients with good success. It is important to make the patient aware of the possible associated serotonergic reactions. If the patient is having more than one headache per week or the headaches are prolonged, prophylactic treatment is indicated. In our practice, the overwhelming majority of these patients will be treated with amitriptyline or topiramate. We generally allow side effect tolerability to guide our choice of medication. Cyproheptadine is often used in younger patients as it comes in a liquid form. There is evidence supporting the use of propranolol, though the potential worsening of underlying asthma symptoms may limit its use, and sodium valproate, which must be used with caution in female patients of childbearing age due to significant teratogenicity risks. Other prophylactic treatments with less robust evidence include the antiepileptic drugs gabapentin, zonisamide, and levetiracetam; calcium channel blockers such as verapamil and amlodipine; and the angiotensin receptor blocking agent candasartin (not available in the USA). Almost all patients in our practice are advised to take magnesium supplementation. Magnesium is a supplement with relatively few adverse effects and good evidence for improvement of migraine symptoms. We evaluate lifestyle issues and comorbidities in all our patients. Ignoring these will make successful treatment near impossible. Good sleep, adequate hydration, appropriate diet, and exercise are vitally important. Finally, most of our patients benefit from a psychology evaluation with cognitive behavioral therapy. Stress management and biofeedback are tremendously helpful in improving quality of life in migraineurs.
Literature
1.
go back to reference Edmeads J. The treatment of headache: a historical perspective. In: Gallagher RM, editor. Therapy for headache. New York: Marcel Dekker INC; 1990. p. 1–8. Edmeads J. The treatment of headache: a historical perspective. In: Gallagher RM, editor. Therapy for headache. New York: Marcel Dekker INC; 1990. p. 1–8.
2.
go back to reference Patterson SM, Silberstein SD. Sometimes Jello helps: perceptions of headache etiology, triggers and treatment in literature. Headache. 1993;33(2):76–81.PubMedCrossRef Patterson SM, Silberstein SD. Sometimes Jello helps: perceptions of headache etiology, triggers and treatment in literature. Headache. 1993;33(2):76–81.PubMedCrossRef
3.
go back to reference Bille B. Migraine in pediatric school children. Acta Paediatr Scand. 1962;51 Suppl 136:1–151. Bille B. Migraine in pediatric school children. Acta Paediatr Scand. 1962;51 Suppl 136:1–151.
4.
go back to reference Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088–97.PubMedCrossRef Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088–97.PubMedCrossRef
5.
go back to reference Wöber-Bingöl C. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep. 2013;17(6):341.PubMedCrossRef Wöber-Bingöl C. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep. 2013;17(6):341.PubMedCrossRef
6.
go back to reference Genizi J, Matar AK, Zelnik N, Schertz M, Srugo I. Frequency of pediatric migraine with aura in a clinic-based sample. Headache. 2016;56(1):113–7.PubMedCrossRef Genizi J, Matar AK, Zelnik N, Schertz M, Srugo I. Frequency of pediatric migraine with aura in a clinic-based sample. Headache. 2016;56(1):113–7.PubMedCrossRef
7.
go back to reference Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache. 2011;51(5):693–706.PubMedCrossRef Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache. 2011;51(5):693–706.PubMedCrossRef
8.
go back to reference Pacheva IH, Ivanov IS. Migraine variants—occurrence in pediatric neurology practice. Clin Neurol Neurosurg. 2013;115(9):1775–83.PubMedCrossRef Pacheva IH, Ivanov IS. Migraine variants—occurrence in pediatric neurology practice. Clin Neurol Neurosurg. 2013;115(9):1775–83.PubMedCrossRef
9.
go back to reference Stokes M, Becker WJ, Lipton RB, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache. 2011;51(7):1058–77.PubMedCrossRef Stokes M, Becker WJ, Lipton RB, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache. 2011;51(7):1058–77.PubMedCrossRef
10.
go back to reference Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;19(5):703–11.PubMedCrossRef Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;19(5):703–11.PubMedCrossRef
11.
go back to reference Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.PubMedCrossRef Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.PubMedCrossRef
12.
go back to reference Rothner AD. The evaluation of headaches in children and adolescents. Semin Pediatr Neurol. 1995;2(2):109–18.PubMedCrossRef Rothner AD. The evaluation of headaches in children and adolescents. Semin Pediatr Neurol. 1995;2(2):109–18.PubMedCrossRef
13.
go back to reference Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006;46(5):766–72.PubMedCrossRef Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006;46(5):766–72.PubMedCrossRef
14.
go back to reference Rutten JK, Lesnick Oberstein SAJ. CADASIL. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews. Seattle: University of Washington; 2000. {Internet}. updated 2016 Jul 14. Rutten JK, Lesnick Oberstein SAJ. CADASIL. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews. Seattle: University of Washington; 2000. {Internet}. updated 2016 Jul 14.
15.
go back to reference Rimkus Cde M, Andrade CS, Leite C, McKinney AM, Lucato LT. Toxic leukoencephalopathies, including drug, medication, environmental and radiation-induced encephalopathic syndromes. Semin Ultrasound CT MR. 2014;35(2):97–117.PubMedCrossRef Rimkus Cde M, Andrade CS, Leite C, McKinney AM, Lucato LT. Toxic leukoencephalopathies, including drug, medication, environmental and radiation-induced encephalopathic syndromes. Semin Ultrasound CT MR. 2014;35(2):97–117.PubMedCrossRef
16.
go back to reference De Giorgis V, Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure. 2013;22(10):802–11.CrossRef De Giorgis V, Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure. 2013;22(10):802–11.CrossRef
18.
go back to reference Stuart S, Griffiths LR. A possible role for mitochondrial dysfunction in migraine. Mol Genet Genomics. 2012;287(11-12):837–44.PubMedCrossRef Stuart S, Griffiths LR. A possible role for mitochondrial dysfunction in migraine. Mol Genet Genomics. 2012;287(11-12):837–44.PubMedCrossRef
19.
go back to reference Sparaco M, Felena M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia. 2006;26:361–72.PubMedCrossRef Sparaco M, Felena M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia. 2006;26:361–72.PubMedCrossRef
20.
go back to reference Wong F, Rayner-Hartley E, Byrne MF. Extraintestinal manifestations of Helicobacter pylori: a concise review. World J Gatroenterol. 2014;20(34):11950–61.CrossRef Wong F, Rayner-Hartley E, Byrne MF. Extraintestinal manifestations of Helicobacter pylori: a concise review. World J Gatroenterol. 2014;20(34):11950–61.CrossRef
21.
go back to reference Spillane J, Kullmann DM, Hanna MG. Genetic neurological channelopathies: molecular genetics and clinical phenotypes. J Neurol Neurosurg Psychiatry. 2016;87(1):37–48.PubMed Spillane J, Kullmann DM, Hanna MG. Genetic neurological channelopathies: molecular genetics and clinical phenotypes. J Neurol Neurosurg Psychiatry. 2016;87(1):37–48.PubMed
22.••
go back to reference Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This is the most recent version of the internationally accepted headache classification, including descriptions of each entity.CrossRef Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This is the most recent version of the internationally accepted headache classification, including descriptions of each entity.CrossRef
23.
go back to reference Rothner AD, Parikh S. Migraine variants or episodic syndromes that may be associated with migraine and other unusual pediatric headache syndromes. Headache. 2016;56(1):206–14.PubMedCrossRef Rothner AD, Parikh S. Migraine variants or episodic syndromes that may be associated with migraine and other unusual pediatric headache syndromes. Headache. 2016;56(1):206–14.PubMedCrossRef
24.
go back to reference Ducros A, Joutel A, Vahedi K, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 1997;42(6):885–90.PubMedCrossRef Ducros A, Joutel A, Vahedi K, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 1997;42(6):885–90.PubMedCrossRef
25.
go back to reference Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology. 2012;79(21):2115–21.PubMedPubMedCentralCrossRef Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology. 2012;79(21):2115–21.PubMedPubMedCentralCrossRef
26.
27.
go back to reference Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia. 2009;29(7):719–28.PubMedCrossRef Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia. 2009;29(7):719–28.PubMedCrossRef
28.
go back to reference Fenichel GM. Clinical pediatric neurology: a signs and symptoms approach. 6th ed. Philadelphia: Saunders Elsevier; 2009. Fenichel GM. Clinical pediatric neurology: a signs and symptoms approach. 6th ed. Philadelphia: Saunders Elsevier; 2009.
30.
go back to reference Peroutka SJ. What turns on a migraine? A systematic review of migraine precipitating factors. Curr Pain Headache Rep. 2014;18(10):454.PubMedCrossRef Peroutka SJ. What turns on a migraine? A systematic review of migraine precipitating factors. Curr Pain Headache Rep. 2014;18(10):454.PubMedCrossRef
31.
go back to reference Arruda MA, Arruda R, Guidetti V, Bigal ME. Psychosocial adjustment of children with migraine and tension-type headache—a nationwide study. Headache. 2015;55 Suppl 1:39–50.PubMedCrossRef Arruda MA, Arruda R, Guidetti V, Bigal ME. Psychosocial adjustment of children with migraine and tension-type headache—a nationwide study. Headache. 2015;55 Suppl 1:39–50.PubMedCrossRef
32.
go back to reference Masruha MR, Lin J, Minett TS, et al. Social anxiety score is high in adolescents with chronic migraine. Pediatr Int. 2012;54(3):393–6.PubMedCrossRef Masruha MR, Lin J, Minett TS, et al. Social anxiety score is high in adolescents with chronic migraine. Pediatr Int. 2012;54(3):393–6.PubMedCrossRef
33.
go back to reference Pavone P, Rizzo I, Conti I, et al. Primary headaches in children: clinical findings on the association with other conditions. Int J Immunopathol Pharmacol. 2012;25(4):1083–91.PubMed Pavone P, Rizzo I, Conti I, et al. Primary headaches in children: clinical findings on the association with other conditions. Int J Immunopathol Pharmacol. 2012;25(4):1083–91.PubMed
34.
go back to reference Pakalnis A, Gibson J, Colvin A. Comorbidity of psychiatric and behavioral disorders in pediatric migraine. Headache. 2005;45(4):590–6.PubMedCrossRef Pakalnis A, Gibson J, Colvin A. Comorbidity of psychiatric and behavioral disorders in pediatric migraine. Headache. 2005;45(4):590–6.PubMedCrossRef
35.
go back to reference Toldo I, Perissinotto E, Menegazzo F, et al. Comorbidity between headache and epilepsy in a pediatric headache center. J Headache Pain. 2010;11(3):235–40.PubMedPubMedCentralCrossRef Toldo I, Perissinotto E, Menegazzo F, et al. Comorbidity between headache and epilepsy in a pediatric headache center. J Headache Pain. 2010;11(3):235–40.PubMedPubMedCentralCrossRef
36.
go back to reference Seidel S, Böck A, Schlegal W, et al. Increased RLS prevalence in children and adolescents with migraine: a case-control study. Cephalalgia. 2012;32(9):693–9.PubMedCrossRef Seidel S, Böck A, Schlegal W, et al. Increased RLS prevalence in children and adolescents with migraine: a case-control study. Cephalalgia. 2012;32(9):693–9.PubMedCrossRef
37.
go back to reference Boccia G, Del Giudice E, Crisanti AF, Strisciuglio C, Romano A, Staiano A. Functional gastrointestinal disorders in migrainous children: efficacy of flunarizine. Cephalalgia. 2006;26(10):1214–9.PubMedCrossRef Boccia G, Del Giudice E, Crisanti AF, Strisciuglio C, Romano A, Staiano A. Functional gastrointestinal disorders in migrainous children: efficacy of flunarizine. Cephalalgia. 2006;26(10):1214–9.PubMedCrossRef
38.
go back to reference Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48(1):103–7.PubMedCrossRef Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48(1):103–7.PubMedCrossRef
39.
go back to reference Tepper DE. Non-steroidal anti-inflammatories for the acute treatment of migraine. Headache. 2012;53(1):225–6.CrossRef Tepper DE. Non-steroidal anti-inflammatories for the acute treatment of migraine. Headache. 2012;53(1):225–6.CrossRef
40.
go back to reference Boureau F, Kappos L, Schoenen J, Esperanca P, Ashford E. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. Int J Clin Pract. 2000;54(5):281–6.PubMed Boureau F, Kappos L, Schoenen J, Esperanca P, Ashford E. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. Int J Clin Pract. 2000;54(5):281–6.PubMed
41.
go back to reference Fujita M, Sato K, Nishioka H, Sakai F. Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study. Cephalalgia. 2014;34(5):365–75.PubMedCrossRef Fujita M, Sato K, Nishioka H, Sakai F. Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study. Cephalalgia. 2014;34(5):365–75.PubMedCrossRef
42.
go back to reference Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache. 2006;46(2):212–22.PubMedCrossRef Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache. 2006;46(2):212–22.PubMedCrossRef
43.
go back to reference Lewis DW, Winner P, Hershey AD, Wasiewski WW, Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007;120(2):390–6.PubMedCrossRef Lewis DW, Winner P, Hershey AD, Wasiewski WW, Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007;120(2):390–6.PubMedCrossRef
44.
go back to reference Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006;67(3):497–9.PubMedCrossRef Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006;67(3):497–9.PubMedCrossRef
45.
go back to reference Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache. 2007;47(4):511–8.PubMedCrossRef Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache. 2007;47(4):511–8.PubMedCrossRef
46.
go back to reference Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012;32(10):750–65.PubMedCrossRef Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012;32(10):750–65.PubMedCrossRef
47.•
go back to reference Sun H, Bastings E, Temeck J, et al. Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents. JAMA Pediatr. 2013;167(3):243–9. Triptans are the most widely used abortive medications for migraine. This is an excellent review of their use in pediatric patients and the difficulty in evaluating their efficacy.PubMedCrossRef Sun H, Bastings E, Temeck J, et al. Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents. JAMA Pediatr. 2013;167(3):243–9. Triptans are the most widely used abortive medications for migraine. This is an excellent review of their use in pediatric patients and the difficulty in evaluating their efficacy.PubMedCrossRef
48.
go back to reference Johnson HF, Goadsby PJ, Gelfand AA. Predictors of triptan response in pediatric migraine. Pediatr Neurol. 2016. [Epub ahead of print]. Johnson HF, Goadsby PJ, Gelfand AA. Predictors of triptan response in pediatric migraine. Pediatr Neurol. 2016. [Epub ahead of print].
49.
go back to reference Evans RW, Tepper SJ, Shapiro RE, Sun-Edelstein C, Tietjen GE. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Headache. 2010;50(6):1089–99.PubMedCrossRef Evans RW, Tepper SJ, Shapiro RE, Sun-Edelstein C, Tietjen GE. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Headache. 2010;50(6):1089–99.PubMedCrossRef
50.
go back to reference Klapper J, Mathew N, Nett R. Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache. 2001;41(10):981–4.PubMedCrossRef Klapper J, Mathew N, Nett R. Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache. 2001;41(10):981–4.PubMedCrossRef
51.
go back to reference Mathew PG, Krel R, Buddhdev B, et al. A retrospective analysis of triptan and DHE use for basilar and hemiplegic migraine. Headache. 2016. [Epub ahead of print]. Mathew PG, Krel R, Buddhdev B, et al. A retrospective analysis of triptan and DHE use for basilar and hemiplegic migraine. Headache. 2016. [Epub ahead of print].
52.
go back to reference Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol. 2007;22(7):829–35.PubMedCrossRef Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol. 2007;22(7):829–35.PubMedCrossRef
53.
go back to reference Fallah R, Divanizadeh MS, Karimi M, Mirouliaei M, Shamszadeh A. Topiramate and propranolol for prophylaxis of migraine. Indian J Pediatr. 2013;80(11):920–4.PubMedCrossRef Fallah R, Divanizadeh MS, Karimi M, Mirouliaei M, Shamszadeh A. Topiramate and propranolol for prophylaxis of migraine. Indian J Pediatr. 2013;80(11):920–4.PubMedCrossRef
54.
go back to reference Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F. Sodium valproate versus propranolol in paediatric migraine prophylaxis. Eur J Pediatr Neurol. 2005;9(5):333–8.CrossRef Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F. Sodium valproate versus propranolol in paediatric migraine prophylaxis. Eur J Pediatr Neurol. 2005;9(5):333–8.CrossRef
55.
go back to reference Bidabadi E, Mashouf M. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. Paediatr Drugs. 2010;12(4):269–75.PubMedCrossRef Bidabadi E, Mashouf M. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. Paediatr Drugs. 2010;12(4):269–75.PubMedCrossRef
56.
57.
go back to reference Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43(6):601–10.PubMedCrossRef Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43(6):601–10.PubMedCrossRef
58.
go back to reference MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol. 2008;23(11):1300–4.PubMedCrossRef MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol. 2008;23(11):1300–4.PubMedCrossRef
59.
go back to reference Cayir A, Turan MI, Tan H. Effect of vitamin D therapy in addition to amitriptyline on migraine attacks in pediatric patients. Braz J Med Biol Res. 2014;47(4):349–54.PubMedPubMedCentralCrossRef Cayir A, Turan MI, Tan H. Effect of vitamin D therapy in addition to amitriptyline on migraine attacks in pediatric patients. Braz J Med Biol Res. 2014;47(4):349–54.PubMedPubMedCentralCrossRef
60.•
go back to reference Kroner JW, Hershey AD, Kashikar-Zuck SM, et al. Cognitive behavioral therapy plus amitriptyline for children and adolescents with chronic migraine reduces headache days to ≤4 per month. Headache. 2016;56(4):711–6. An excellent study reinforcing the benefit of cognitive behavioral therapy for pediatric migraineurs.PubMedCrossRef Kroner JW, Hershey AD, Kashikar-Zuck SM, et al. Cognitive behavioral therapy plus amitriptyline for children and adolescents with chronic migraine reduces headache days to ≤4 per month. Headache. 2016;56(4):711–6. An excellent study reinforcing the benefit of cognitive behavioral therapy for pediatric migraineurs.PubMedCrossRef
61.•
go back to reference Kabbouche MA. Management of pediatric migraine headache in the emergency room and infusion center. Headache. 2015;55(10):1365–70. A comprehensive review of ER treatment options for pediatric migraineurs.PubMedCrossRef Kabbouche MA. Management of pediatric migraine headache in the emergency room and infusion center. Headache. 2015;55(10):1365–70. A comprehensive review of ER treatment options for pediatric migraineurs.PubMedCrossRef
62.
go back to reference Sheridan DC, Spiro DM, Meckler GD. Pediatric migraine: abortive management in the emergency department. Headache. 2014;54(2):235–45.PubMedCrossRef Sheridan DC, Spiro DM, Meckler GD. Pediatric migraine: abortive management in the emergency department. Headache. 2014;54(2):235–45.PubMedCrossRef
64.
go back to reference Leung S, Bulloch B, Young C, Yonker M, Hostetler M. Effectiveness of standardized combination therapy for migraine treatment in the pediatric emergency department. Headache. 2013;53(3):491–7.PubMedCrossRef Leung S, Bulloch B, Young C, Yonker M, Hostetler M. Effectiveness of standardized combination therapy for migraine treatment in the pediatric emergency department. Headache. 2013;53(3):491–7.PubMedCrossRef
65.
go back to reference Legault G, Eisman H, Shevell M. Treatment of pediatric status migrainosus: can we prevent the “bounce back”? J Child Neurol. 2011;26(8):949–55.PubMedCrossRef Legault G, Eisman H, Shevell M. Treatment of pediatric status migrainosus: can we prevent the “bounce back”? J Child Neurol. 2011;26(8):949–55.PubMedCrossRef
66.
go back to reference Trottier ED, Bailey B, Lucas N, Lortie A. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Am J Emerg Med. 2012;30(3):456–63.PubMedCrossRef Trottier ED, Bailey B, Lucas N, Lortie A. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Am J Emerg Med. 2012;30(3):456–63.PubMedCrossRef
67.•
go back to reference Kabbouche MA. Pediatric inpatient headache therapy: what is available. Headache. 2015;55(10):1426–9. As with #61 above, a comprehensive review of inpatient therapy.PubMedCrossRef Kabbouche MA. Pediatric inpatient headache therapy: what is available. Headache. 2015;55(10):1426–9. As with #61 above, a comprehensive review of inpatient therapy.PubMedCrossRef
68.
go back to reference Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache. 1994;34(10):578–80.PubMedCrossRef Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache. 1994;34(10):578–80.PubMedCrossRef
69.
go back to reference Winner P, Lewis DW, Rothner AD. Headache in children and adolescents. 2nd ed. New York: BC Decker; 2008. Winner P, Lewis DW, Rothner AD. Headache in children and adolescents. 2nd ed. New York: BC Decker; 2008.
70.
go back to reference O’Brien HL, Kabbouche MA, Kacperski J, Hershey AD. Treatment of pediatric migraine. Curr Treat Options Neurol. 2015;17(1):1–17.CrossRef O’Brien HL, Kabbouche MA, Kacperski J, Hershey AD. Treatment of pediatric migraine. Curr Treat Options Neurol. 2015;17(1):1–17.CrossRef
71.
go back to reference Hershey AD, Powers SW, Winner P, Kabbouche MA. Pediatric headache in clinical practice. West Sussex: Wiley-Blackwell; 2009.CrossRef Hershey AD, Powers SW, Winner P, Kabbouche MA. Pediatric headache in clinical practice. West Sussex: Wiley-Blackwell; 2009.CrossRef
72.
go back to reference Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183–7.PubMedCrossRef Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183–7.PubMedCrossRef
73.
go back to reference Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33(1):48–56.PubMedCrossRef Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33(1):48–56.PubMedCrossRef
74.
go back to reference Hansen JM, Hauge AW, Oesen J, Ashina M. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010;30(10):1179–86.PubMedCrossRef Hansen JM, Hauge AW, Oesen J, Ashina M. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010;30(10):1179–86.PubMedCrossRef
75.
Metadata
Title
Diagnosis and Treatment of Childhood Migraine
Authors
Kelsey Merison, MD
Howard Jacobs, MD
Publication date
01-11-2016
Publisher
Springer US
Published in
Current Treatment Options in Neurology / Issue 11/2016
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-016-0431-4